RIGEL PHARMACEUTICALS INC Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Rigel Pharmaceuticals Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • Rigel Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.64M, a 36.1% increase year-over-year.
  • Rigel Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $12.2M, a 11.7% increase year-over-year.
  • Rigel Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2023 was $8.81M, a 28.9% decline from 2022.
  • Rigel Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2022 was $12.4M, a 30.6% increase from 2021.
  • Rigel Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2021 was $9.49M, a 30% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $8.81M -$3.58M -28.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $12.4M +$2.9M +30.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $9.49M +$2.19M +30% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-05
2020 $7.3M -$1.82M -20% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-07
2019 $9.12M +$1.41M +18.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $7.7M +$1.72M +28.7% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-02
2017 $5.99M -$1.85M -23.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $7.83M +$429K +5.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $7.4M -$2.38M -24.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-06
2014 $9.79M +$2.62M +36.6% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-07
2013 $7.17M -$5.45M -43.2% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-08
2012 $12.6M -$551K -4.18% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-03
2011 $13.2M -$3.27M -19.9% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-04
2010 $16.4M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.